Search for stocks /

Laxmi Organic Industries Ltd Q2FY26 – The Solvent Samurai Strikes Again: ₹700 Cr Revenue, ₹11 Cr Profit, and a Dahej Dream Worth ₹1,100 Cr!


1. At a Glance

Laxmi Organic Industries Ltd, the 35-year-old warrior of solvents and specialty chemistry, just dropped its Q2FY26 results — and let’s just say, the numbers are less Breaking Bad, more “Breaking Even.” The company clocked ₹700 crore in sales and ₹11 crore PAT, marking a -9% YoY revenue dip and a -61% YoY profit fall. The operating margin? 7% — not terrible, but not exactly chemistry on fire.

With a market cap of ₹5,631 crore and a P/E of 67.5, the stock seems to think it’s in the Pidilite or Navin Fluorine club. Meanwhile, ROE at 5.93% and ROCE at 8.56% say, “Bro, calm down.” The stock trades at ₹203, a long way from its ₹284 high, but thankfully above the ₹160 “please-hold-your-breath” low.

Still, there’s reason to watch. A ₹1,100 crore capex spree is underway, a Dahej mega-plant is nearing completion, and a proposed merger with Yellowstone Fine Chemicals could finally make their fluorospecialty segment explode faster than an exothermic reaction.


2. Introduction

If the Indian chemicals industry were a Bollywood family drama, Laxmi Organic would be the middle child — reliable, overshadowed, and trying really hard to get noticed while Pidilite and Deepak Nitrite steal the limelight.

Founded in 1989, this Mumbai-based company has grown from making basic acetates to sophisticated Diketene Derivative Products (DDPs) — the stuff that goes into everything from painkillers to paints to pesticides. It’s now a 650+ customer global network spanning 52 countries, with a balance sheet that screams “steady compounder… someday.”

But the short-term story isn’t all rosy. Global demand for acetates has cooled, crude prices and Chinese dumping have squeezed margins, and the “specialty” business hasn’t yet delivered “special” returns. However, management has been doubling down — new capacities, new chemistries, and new geographies.

Will Laxmi’s ₹1,100 crore capex plan finally make it sparkle like Navin Fluorine or remain the quiet “solvent supplier next door”?


3. Business Model – WTF Do They Even Do?

In short: they sell chemicals you’ve probably inhaled without knowing it.

Two Segments. One Mission: Keep industries running (and noses burning).

🧪 Essentials Segment (Mass Market)

Think of it as the company’s bread and butter — or rather, ethanol and acetate.
Products: Ethyl Acetate, Acetic Anhydride, Acetaldehyde, n-Butyl Acetate, Ethanol.
Uses: Pharma, packaging, industrial coatings, and printing inks.
Contribution to EBITDA: 32% (9MFY25)

⚗️ Specialty Segment (High-Margin Science)

Here’s where the “smart chemistry” happens — Ketene, Diketene derivatives, esters, amides, fluorospecialties, and arylides.
Customers: Pharma, agrochemicals, pigments, coatings, and even electronics.
Contribution to EBITDA: 68% (9MFY25)

Geographical Mix:

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!